author_facet Liu, Tao
Xu, Jing
Wu, Yungang
Li, Xiaoxia
Ding, Detao
Ma, Dengdian
Yao, Mengwei
Wei, Wenzhong
Zhang, Wei
Wang, Shaohua
Yao, Jing
Li, Xiaoyu
Liu, Tao
Xu, Jing
Wu, Yungang
Li, Xiaoxia
Ding, Detao
Ma, Dengdian
Yao, Mengwei
Wei, Wenzhong
Zhang, Wei
Wang, Shaohua
Yao, Jing
Li, Xiaoyu
author Liu, Tao
Xu, Jing
Wu, Yungang
Li, Xiaoxia
Ding, Detao
Ma, Dengdian
Yao, Mengwei
Wei, Wenzhong
Zhang, Wei
Wang, Shaohua
Yao, Jing
Li, Xiaoyu
spellingShingle Liu, Tao
Xu, Jing
Wu, Yungang
Li, Xiaoxia
Ding, Detao
Ma, Dengdian
Yao, Mengwei
Wei, Wenzhong
Zhang, Wei
Wang, Shaohua
Yao, Jing
Li, Xiaoyu
Acta Pharmaceutica
Beneficial effects of baicalein on a model of allergic rhinitis
Pharmaceutical Science
Pharmacology
General Medicine
author_sort liu, tao
spelling Liu, Tao Xu, Jing Wu, Yungang Li, Xiaoxia Ding, Detao Ma, Dengdian Yao, Mengwei Wei, Wenzhong Zhang, Wei Wang, Shaohua Yao, Jing Li, Xiaoyu 1846-9558 Walter de Gruyter GmbH Pharmaceutical Science Pharmacology General Medicine http://dx.doi.org/10.2478/acph-2020-0009 <jats:title>Abstract</jats:title> <jats:p>Allergic rhinitis (AR) is a common disease that causes severe inflammation and even disabilities. Previous studies have reported baicalein to have an anti-inflammatory effect. However, the pharmacological action of baicalein on anaphylaxis has not been clarified yet. This study assessed the <jats:italic>in vivo</jats:italic> protective effect of baicalein post-treatment in an ameliorating ovalbumin (OVA)-sensitized AR rat model. Baicalein attenuated histological alterations, aberrant tissue repair and inflammation after OVA-induced AR. Baicalein reduced the frequency of nasal/ear rubs and sneezes in rats, and inhibited generation of several inflammatory cytokines (TNF-α, IL-1β, and IL-6) in both blood and nasal lavage of rats. Infiltrations of eosinophils, lymphocyte, and neutrophils were decreased in baicalein-administered rats. Furthermore, baicalein inhibited the expression of STAT3 phosphorylation in the nasal mucosa. In summary, baicalein attenuated OVA-induced AR and inflammation, which suggests it as a promising therapeutic agent for the alleviation of AR-associated inflammation and pathology.</jats:p> Beneficial effects of baicalein on a model of allergic rhinitis Acta Pharmaceutica
doi_str_mv 10.2478/acph-2020-0009
facet_avail Online
Free
finc_class_facet Chemie und Pharmazie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjQ3OC9hY3BoLTIwMjAtMDAwOQ
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjQ3OC9hY3BoLTIwMjAtMDAwOQ
institution DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
imprint Walter de Gruyter GmbH, 2020
imprint_str_mv Walter de Gruyter GmbH, 2020
issn 1846-9558
issn_str_mv 1846-9558
language English
mega_collection Walter de Gruyter GmbH (CrossRef)
match_str liu2020beneficialeffectsofbaicaleinonamodelofallergicrhinitis
publishDateSort 2020
publisher Walter de Gruyter GmbH
recordtype ai
record_format ai
series Acta Pharmaceutica
source_id 49
title Beneficial effects of baicalein on a model of allergic rhinitis
title_unstemmed Beneficial effects of baicalein on a model of allergic rhinitis
title_full Beneficial effects of baicalein on a model of allergic rhinitis
title_fullStr Beneficial effects of baicalein on a model of allergic rhinitis
title_full_unstemmed Beneficial effects of baicalein on a model of allergic rhinitis
title_short Beneficial effects of baicalein on a model of allergic rhinitis
title_sort beneficial effects of baicalein on a model of allergic rhinitis
topic Pharmaceutical Science
Pharmacology
General Medicine
url http://dx.doi.org/10.2478/acph-2020-0009
publishDate 2020
physical 35-47
description <jats:title>Abstract</jats:title> <jats:p>Allergic rhinitis (AR) is a common disease that causes severe inflammation and even disabilities. Previous studies have reported baicalein to have an anti-inflammatory effect. However, the pharmacological action of baicalein on anaphylaxis has not been clarified yet. This study assessed the <jats:italic>in vivo</jats:italic> protective effect of baicalein post-treatment in an ameliorating ovalbumin (OVA)-sensitized AR rat model. Baicalein attenuated histological alterations, aberrant tissue repair and inflammation after OVA-induced AR. Baicalein reduced the frequency of nasal/ear rubs and sneezes in rats, and inhibited generation of several inflammatory cytokines (TNF-α, IL-1β, and IL-6) in both blood and nasal lavage of rats. Infiltrations of eosinophils, lymphocyte, and neutrophils were decreased in baicalein-administered rats. Furthermore, baicalein inhibited the expression of STAT3 phosphorylation in the nasal mucosa. In summary, baicalein attenuated OVA-induced AR and inflammation, which suggests it as a promising therapeutic agent for the alleviation of AR-associated inflammation and pathology.</jats:p>
container_issue 1
container_start_page 35
container_title Acta Pharmaceutica
container_volume 70
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792347778791243776
geogr_code not assigned
last_indexed 2024-03-01T18:00:40.296Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Beneficial+effects+of+baicalein+on+a+model+of+allergic+rhinitis&rft.date=2020-03-01&genre=article&issn=1846-9558&volume=70&issue=1&spage=35&epage=47&pages=35-47&jtitle=Acta+Pharmaceutica&atitle=Beneficial+effects+of+baicalein+on+a+model+of+allergic+rhinitis&aulast=Li&aufirst=Xiaoyu&rft_id=info%3Adoi%2F10.2478%2Facph-2020-0009&rft.language%5B0%5D=eng
SOLR
_version_ 1792347778791243776
author Liu, Tao, Xu, Jing, Wu, Yungang, Li, Xiaoxia, Ding, Detao, Ma, Dengdian, Yao, Mengwei, Wei, Wenzhong, Zhang, Wei, Wang, Shaohua, Yao, Jing, Li, Xiaoyu
author_facet Liu, Tao, Xu, Jing, Wu, Yungang, Li, Xiaoxia, Ding, Detao, Ma, Dengdian, Yao, Mengwei, Wei, Wenzhong, Zhang, Wei, Wang, Shaohua, Yao, Jing, Li, Xiaoyu, Liu, Tao, Xu, Jing, Wu, Yungang, Li, Xiaoxia, Ding, Detao, Ma, Dengdian, Yao, Mengwei, Wei, Wenzhong, Zhang, Wei, Wang, Shaohua, Yao, Jing, Li, Xiaoyu
author_sort liu, tao
container_issue 1
container_start_page 35
container_title Acta Pharmaceutica
container_volume 70
description <jats:title>Abstract</jats:title> <jats:p>Allergic rhinitis (AR) is a common disease that causes severe inflammation and even disabilities. Previous studies have reported baicalein to have an anti-inflammatory effect. However, the pharmacological action of baicalein on anaphylaxis has not been clarified yet. This study assessed the <jats:italic>in vivo</jats:italic> protective effect of baicalein post-treatment in an ameliorating ovalbumin (OVA)-sensitized AR rat model. Baicalein attenuated histological alterations, aberrant tissue repair and inflammation after OVA-induced AR. Baicalein reduced the frequency of nasal/ear rubs and sneezes in rats, and inhibited generation of several inflammatory cytokines (TNF-α, IL-1β, and IL-6) in both blood and nasal lavage of rats. Infiltrations of eosinophils, lymphocyte, and neutrophils were decreased in baicalein-administered rats. Furthermore, baicalein inhibited the expression of STAT3 phosphorylation in the nasal mucosa. In summary, baicalein attenuated OVA-induced AR and inflammation, which suggests it as a promising therapeutic agent for the alleviation of AR-associated inflammation and pathology.</jats:p>
doi_str_mv 10.2478/acph-2020-0009
facet_avail Online, Free
finc_class_facet Chemie und Pharmazie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjQ3OC9hY3BoLTIwMjAtMDAwOQ
imprint Walter de Gruyter GmbH, 2020
imprint_str_mv Walter de Gruyter GmbH, 2020
institution DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3
issn 1846-9558
issn_str_mv 1846-9558
language English
last_indexed 2024-03-01T18:00:40.296Z
match_str liu2020beneficialeffectsofbaicaleinonamodelofallergicrhinitis
mega_collection Walter de Gruyter GmbH (CrossRef)
physical 35-47
publishDate 2020
publishDateSort 2020
publisher Walter de Gruyter GmbH
record_format ai
recordtype ai
series Acta Pharmaceutica
source_id 49
spelling Liu, Tao Xu, Jing Wu, Yungang Li, Xiaoxia Ding, Detao Ma, Dengdian Yao, Mengwei Wei, Wenzhong Zhang, Wei Wang, Shaohua Yao, Jing Li, Xiaoyu 1846-9558 Walter de Gruyter GmbH Pharmaceutical Science Pharmacology General Medicine http://dx.doi.org/10.2478/acph-2020-0009 <jats:title>Abstract</jats:title> <jats:p>Allergic rhinitis (AR) is a common disease that causes severe inflammation and even disabilities. Previous studies have reported baicalein to have an anti-inflammatory effect. However, the pharmacological action of baicalein on anaphylaxis has not been clarified yet. This study assessed the <jats:italic>in vivo</jats:italic> protective effect of baicalein post-treatment in an ameliorating ovalbumin (OVA)-sensitized AR rat model. Baicalein attenuated histological alterations, aberrant tissue repair and inflammation after OVA-induced AR. Baicalein reduced the frequency of nasal/ear rubs and sneezes in rats, and inhibited generation of several inflammatory cytokines (TNF-α, IL-1β, and IL-6) in both blood and nasal lavage of rats. Infiltrations of eosinophils, lymphocyte, and neutrophils were decreased in baicalein-administered rats. Furthermore, baicalein inhibited the expression of STAT3 phosphorylation in the nasal mucosa. In summary, baicalein attenuated OVA-induced AR and inflammation, which suggests it as a promising therapeutic agent for the alleviation of AR-associated inflammation and pathology.</jats:p> Beneficial effects of baicalein on a model of allergic rhinitis Acta Pharmaceutica
spellingShingle Liu, Tao, Xu, Jing, Wu, Yungang, Li, Xiaoxia, Ding, Detao, Ma, Dengdian, Yao, Mengwei, Wei, Wenzhong, Zhang, Wei, Wang, Shaohua, Yao, Jing, Li, Xiaoyu, Acta Pharmaceutica, Beneficial effects of baicalein on a model of allergic rhinitis, Pharmaceutical Science, Pharmacology, General Medicine
title Beneficial effects of baicalein on a model of allergic rhinitis
title_full Beneficial effects of baicalein on a model of allergic rhinitis
title_fullStr Beneficial effects of baicalein on a model of allergic rhinitis
title_full_unstemmed Beneficial effects of baicalein on a model of allergic rhinitis
title_short Beneficial effects of baicalein on a model of allergic rhinitis
title_sort beneficial effects of baicalein on a model of allergic rhinitis
title_unstemmed Beneficial effects of baicalein on a model of allergic rhinitis
topic Pharmaceutical Science, Pharmacology, General Medicine
url http://dx.doi.org/10.2478/acph-2020-0009